Hollencrest Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Hollencrest Capital Management's PFE Position: Q2 2026 in Review
Hollencrest Capital Management increased its Pfizer (PFE) stake by 2.1% in Q2 2026, buying an estimated $471 and bringing the position to 881 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #718.
Hollencrest Capital Management first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $12.3M in Q1 2015. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Hollencrest Capital Management held 881 shares of Pfizer worth $21.2K as of Q2 2026.
- Hollencrest Capital Management bought 18 Pfizer shares in Q2 2026, an estimated $471.
- Pfizer made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #718 holding.
- Hollencrest Capital Management first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
- Hollencrest Capital Management's Pfizer position peaked at $12.3M in Q1 2015.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.